Yaman Lu

1.1k total citations
25 papers, 781 citations indexed

About

Yaman Lu is a scholar working on Neurology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Yaman Lu has authored 25 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Neurology, 12 papers in Physiology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Yaman Lu's work include Neuroinflammation and Neurodegeneration Mechanisms (18 papers), Alzheimer's disease research and treatments (12 papers) and Tryptophan and brain disorders (6 papers). Yaman Lu is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (18 papers), Alzheimer's disease research and treatments (12 papers) and Tryptophan and brain disorders (6 papers). Yaman Lu collaborates with scholars based in United States, Egypt and China. Yaman Lu's co-authors include Howard E. Gendelman, R. Lee Mosley, Tomomi Kiyota, Katherine E. Olson, Jatin Machhi, Krista L. Namminga, Honghong Yao, Shilpa Buch, Mai Mohamed Abdelmoaty and Pravin Yeapuri and has published in prestigious journals such as PLoS ONE, Biomaterials and Journal of Controlled Release.

In The Last Decade

Yaman Lu

25 papers receiving 776 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yaman Lu United States 17 382 245 189 176 173 25 781
Katherine E. Olson United States 19 578 1.5× 244 1.0× 372 2.0× 272 1.5× 209 1.2× 25 999
Melissa Cosenza-Nashat United States 7 255 0.7× 124 0.5× 55 0.3× 108 0.6× 148 0.9× 7 596
Mathias Linnerbauer Germany 11 624 1.6× 222 0.9× 127 0.7× 163 0.9× 386 2.2× 15 1.2k
Susanna Mantovani Australia 13 410 1.1× 201 0.8× 349 1.8× 166 0.9× 606 3.5× 17 1.3k
B J Balin United States 9 176 0.5× 256 1.0× 127 0.7× 102 0.6× 214 1.2× 10 661
Javier María Peralta Ramos Argentina 12 278 0.7× 128 0.5× 106 0.6× 79 0.4× 171 1.0× 17 653
Ethan R. Roy United States 8 451 1.2× 250 1.0× 63 0.3× 47 0.3× 251 1.5× 14 777
Mark A. Rivieccio United States 9 273 0.7× 80 0.3× 65 0.3× 223 1.3× 593 3.4× 10 1.1k
Yuqiang Shi China 19 111 0.3× 397 1.6× 112 0.6× 304 1.7× 233 1.3× 28 888
Joyce Tran United States 11 213 0.6× 315 1.3× 110 0.6× 52 0.3× 628 3.6× 12 997

Countries citing papers authored by Yaman Lu

Since Specialization
Citations

This map shows the geographic impact of Yaman Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaman Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaman Lu more than expected).

Fields of papers citing papers by Yaman Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaman Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaman Lu. The network helps show where Yaman Lu may publish in the future.

Co-authorship network of co-authors of Yaman Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yaman Lu. A scholar is included among the top collaborators of Yaman Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaman Lu. Yaman Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yeapuri, Pravin, Yaman Lu, Chen Zhang, et al.. (2025). HIV-1 infection facilitates Alzheimer’s disease pathology in humanized APP knock-in immunodeficient mice. PubMed. 4(1). 27–38. 2 indexed citations
2.
Yeapuri, Pravin, Jatin Machhi, Yaman Lu, et al.. (2025). Amyloid precursor protein and presenilin‐1 knock‐in immunodeficient mice exhibit intraneuronal Aβ pathology, microgliosis, and extensive neuronal loss. Alzheimer s & Dementia. 21(4). e70084–e70084. 3 indexed citations
3.
Abdelmoaty, Mai Mohamed, Pravin Yeapuri, Jatin Machhi, et al.. (2023). Immune senescence in aged APP/PS1 mice. PubMed. 2(3). 317–330. 4 indexed citations
4.
Olson, Katherine E., Mai Mohamed Abdelmoaty, Krista L. Namminga, et al.. (2023). An open-label multiyear study of sargramostim-treated Parkinson’s disease patients examining drug safety, tolerability, and immune biomarkers from limited case numbers. Translational Neurodegeneration. 12(1). 26–26. 16 indexed citations
5.
Yeapuri, Pravin, Jatin Machhi, Yaman Lu, et al.. (2023). Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice. Molecular Neurodegeneration. 18(1). 97–97. 36 indexed citations
6.
Yeapuri, Pravin, Katherine E. Olson, Yaman Lu, et al.. (2022). Development of an extended half-life GM-CSF fusion protein for Parkinson's disease. Journal of Controlled Release. 348. 951–965. 19 indexed citations
7.
Machhi, Jatin, Pravin Yeapuri, Yaman Lu, et al.. (2021). CD4+ effector T cells accelerate Alzheimer’s disease in mice. Journal of Neuroinflammation. 18(1). 272–272. 96 indexed citations
8.
Olson, Katherine E., Krista L. Namminga, Yaman Lu, et al.. (2021). Granulocyte-macrophage colony-stimulating factor mRNA and Neuroprotective Immunity in Parkinson's disease. Biomaterials. 272. 120786–120786. 38 indexed citations
9.
Olson, Katherine E., Krista L. Namminga, Yaman Lu, et al.. (2021). Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's disease. EBioMedicine. 67. 103380–103380. 35 indexed citations
10.
Olson, Katherine E., Krista L. Namminga, Aaron Schwab, et al.. (2020). Neuroprotective Activities of Long-Acting Granulocyte–Macrophage Colony-Stimulating Factor (mPDM608) in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Intoxicated Mice. Neurotherapeutics. 17(4). 1861–1877. 25 indexed citations
11.
Kiyota, Tomomi, Jatin Machhi, Yaman Lu, et al.. (2018). URMC-099 facilitates amyloid-β clearance in a murine model of Alzheimer’s disease. Journal of Neuroinflammation. 15(1). 137–137. 30 indexed citations
12.
Kiyota, Tomomi, Jatin Machhi, Yaman Lu, et al.. (2018). Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer’s disease mice. Journal of Neuroimmunology. 319. 80–92. 58 indexed citations
13.
Gendelman, Howard E., Yuning Zhang, Pamela M. Santamaria, et al.. (2017). Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson’s disease trial. npj Parkinson s Disease. 3(1). 10–10. 107 indexed citations
14.
Embury, Christine M., et al.. (2016). Cathepsin B Improves ß-Amyloidosis and Learning and Memory in Models of Alzheimer’s Disease. Journal of Neuroimmune Pharmacology. 12(2). 340–352. 58 indexed citations
15.
Dong, Weiguo, Christine M. Embury, Yaman Lu, et al.. (2016). The mixed-lineage kinase 3 inhibitor URMC-099 facilitates microglial amyloid-β degradation. Journal of Neuroinflammation. 13(1). 184–184. 23 indexed citations
16.
Warren, Galya, Edward Makarov, Yaman Lu, et al.. (2015). Amphiphilic Cationic Nanogels as Brain-Targeted Carriers for Activated Nucleoside Reverse Transcriptase Inhibitors. Journal of Neuroimmune Pharmacology. 10(1). 88–101. 18 indexed citations
17.
Kiyota, Tomomi, Gang Zhang, Megan E. Bosch, et al.. (2015). AAV2/1 CD74 Gene Transfer Reduces β-amyloidosis and Improves Learning and Memory in a Mouse Model of Alzheimer's Disease. Molecular Therapy. 23(11). 1712–1721. 34 indexed citations
18.
Senanayake, Thulani H., et al.. (2014). Encapsulation of Poorly Soluble Drugs in Polymer-Drug Conjugates: Effect of Dual-Drug Nanoformulations on Cancer Therapy. Pharmaceutical Research. 31(6). 1605–1615. 7 indexed citations
19.
Wen, Hongxiu, Yaman Lu, Honghong Yao, & Shilpa Buch. (2011). Morphine Induces Expression of Platelet-Derived Growth Factor in Human Brain Microvascular Endothelial Cells: Implication for Vascular Permeability. PLoS ONE. 6(6). e21707–e21707. 45 indexed citations
20.
Yang, Yanjing, Honghong Yao, Yaman Lu, Chao Wang, & Shilpa Buch. (2010). Cocaine Potentiates Astrocyte Toxicity Mediated by Human Immunodeficiency Virus (HIV-1) Protein gp120. PLoS ONE. 5(10). e13427–e13427. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katherine E. Olson Breakdown of academic impact, for papers by Melissa Cosenza-Nashat Breakdown of academic impact, for papers by Mathias Linnerbauer Breakdown of academic impact, for papers by Susanna Mantovani Breakdown of academic impact, for papers by B J Balin Breakdown of academic impact, for papers by Javier María Peralta Ramos Breakdown of academic impact, for papers by Ethan R. Roy Breakdown of academic impact, for papers by Mark A. Rivieccio Breakdown of academic impact, for papers by Yuqiang Shi Breakdown of academic impact, for papers by Joyce Tran
Rankless by CCL
2026